Best case scenario: They start the trial in 01.09.2020 take half a year trial 01.03.2021 and wait one year for approval which takes in best case 1 year. So best case 01.03.2022.
Now lets take a look at a realistic timeline:
Start 01.09.2020
End of enrolement (sasumed needed 15 month for phase 3 enrolement) 01.12.2021
End of trial (6 month later) 01.06.2022
Getting approval (takes 12-18 month so lets assume 15) 01.09.2023
And that is really a realistic approximation and not a conservative. And keep in mind that half of the phase 3 trial candidates are droped by the developing company during or after the pase 3 trial and half of the ones, that are not droped are rejected by the fda.
So a realistically we have a 25% chance it hits the market 01.09.2023 and best case it hits the market 01.03.2022.